Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added; the government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide funding status notice was added, and the page was updated to Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a 'Show glossary' control and updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older label variants like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed or altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed; the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page consolidates site locations under a single 'Locations' section with an expanded worldwide list, replacing multiple country/city-specific location subsections. This changes how users locate and contact trial sites.SummaryDifference2%

- Check91 days agoChange DetectedPublications section updated to indicate that items are automatically filled from PubMed and may not all relate to the study. The revision tag was updated to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.